CIK 0001745999 · Large accelerated filer
Beam Therapeutics Inc.
Sign in to watch- Ticker
- BEAM
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 857-327-8775
- Business address
- 26 LANDSDOWNE STREET, CAMBRIDGE, MA, 02139
- Former names
- Beam Therapeutics Inc.
- 4 Open-market sale President & CSO sold 29,393 shares at an average $85.62 ($2,516,672)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 10-Q Report Quarterly Report
- 8-K Event Results of operations · Executive or director change
- 4 Open-market sale CEO sold 47,700 shares at an average $83.80 ($3,997,268)
- 4 Option exercise President & CSO acquired 18,012 shares (option exercise)
- 4/A Derivatives Options or other derivatives
- 4/A Derivatives Options or other derivatives
- 4 Other disposition See Remark 1 disposed of 2,600,505 shares (other)
- 4 Open-market sale CEO sold 20,000 shares at an average $99.49 ($1,989,744)
- 4/A Other disposition 10% owner disposed of 1,913,277 shares (other)
- 4 Other disposition See Remark 1 disposed of 1,913,277 shares (other)
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 4 Open-market sale Director sold 2,614 shares at an average $120.61 ($315,263)
- 4 Open-market sale CEO sold 25,000 shares at an average $107.87 ($2,696,826)
- 424B5 Offering Prospectus
- 8-K Event Material agreement · Other events
- 4 Open-market sale CFO sold 30,000 shares at an average $122.00 ($3,660,000)
Page 19 of 26 · 514 filings